<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: We retrospectively analyzed preoperative levels of carbohydrate antigen (CA) 19-9 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients to determine the prognostic value of CA19-9 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with <z:mpath ids='MPATH_458'>normal</z:mpath> carcinoembryonic antigen (CEA) levels </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 639 patients who underwent curative surgery at Taipei Veterans General Hospital between 2002 and 2006 were enrolled </plain></SENT>
<SENT sid="2" pm="."><plain>We excluded 254 patients (39.7 %) with high preoperative CEA levels and analyzed 385 patients with <z:mpath ids='MPATH_458'>normal</z:mpath> CEA levels </plain></SENT>
<SENT sid="3" pm="."><plain>The measured endpoint was the postoperative disease-free survival (DFS) </plain></SENT>
<SENT sid="4" pm="."><plain>The prognostic value of CA19-9 was determined using log-rank test and Cox regression analysis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: High CA19-9 levels were significantly associated with advanced disease and were detected in 5.8 % of patients with stage I disease, 11.7 % of those with stage II disease, and 22.5 % of those with stage III disease (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The 5-year DFS in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> CA19-9 levels was 82.0 %, which was significantly higher than that in patients with high CA19-9 levels (68 %; P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>In a multivariate analysis, the most important independent factor affecting the 5-year DFS was <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> stage (95 % CI, 1.26-2.36; HR = 1.72) </plain></SENT>
<SENT sid="8" pm="."><plain>After stratification by other factors, high CA19-9 level remained an independent prognostic factor for patients with <z:mpath ids='MPATH_458'>normal</z:mpath> CEA levels </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with high CA19-9 levels also showed a higher incidence of lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (23.1 %) than those with <z:mpath ids='MPATH_458'>normal</z:mpath> CA19-9 levels (7.2 %) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: CA19-9 may be a prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with <z:mpath ids='MPATH_458'>normal</z:mpath> CEA levels </plain></SENT>
<SENT sid="11" pm="."><plain>An aggressive follow-up protocol for lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> should be used for these patients </plain></SENT>
</text></document>